A 52-year-old woman from urban Delhi presents with a 3-year history of hypertension (currently 156/98 mmHg on no treatment). She works as an accountant, is sedentary, and reports high occupational stress. BMI is 28.5 kg/m². She denies smoking and alcohol. Fasting lipid profile: total cholesterol 198 mg/dL, LDL 125 mg/dL, HDL 38 mg/dL, triglycerides 165 mg/dL. Fasting glucose 102 mg/dL. She has no family history of premature CAD. According to Indian CVD epidemiology and the concept of absolute cardiovascular risk, what is the PRIMARY reason this patient's CVD risk is substantially higher than a normotensive woman of the same age and BMI?

Explanation

## Hypertension as the Primary Driver of CVD Risk in This Patient **Key Point:** Hypertension is the single most important modifiable risk factor for CVD in India and globally. Sustained elevation of blood pressure causes endothelial dysfunction, arterial remodeling, and increased arterial stiffness — the pathophysiological basis for dramatically elevated CVD risk. ### Pathophysiology of Hypertension-Induced Vascular Damage 1. **Endothelial Dysfunction:** - Chronic hypertension impairs endothelial nitric oxide (NO) production - Loss of NO → increased vasoconstriction, platelet aggregation, and LDL oxidation - Endothelial permeability increases → lipid infiltration and atherosclerosis initiation 2. **Arterial Stiffness and Remodeling:** - Sustained pressure overload → medial hypertrophy and increased collagen/elastin cross-linking - Increased pulse pressure → greater myocardial oxygen demand and LV hypertrophy - Reduced arterial compliance → impaired diastolic relaxation and coronary perfusion 3. **Absolute CVD Risk Elevation:** - A 52-year-old woman with stage 2 hypertension (156/98 mmHg) has a 10-year absolute CVD risk of ~15–20% (using Framingham or Indian CVD risk calculator) - A normotensive woman of the same age, BMI, and lipid profile would have a risk of ~5–8% - This 2–3 fold increase is driven primarily by hypertension, not by modest LDL or low HDL in isolation ### Why Other Options Are Secondary or Incorrect | Risk Factor | Status in This Patient | Impact on Risk | |---|---|---| | **Hypertension** | 156/98 mmHg (Stage 2) | **PRIMARY** — drives endothelial dysfunction, arterial stiffness, LV hypertrophy | | LDL cholesterol | 125 mg/dL (borderline high) | Secondary — modest elevation; risk is multiplicative with hypertension | | HDL cholesterol | 38 mg/dL (low) | Secondary — contributes to dyslipidemia profile but not diagnostic of genetic FH | | Fasting glucose | 102 mg/dL (impaired fasting glucose, not diabetes) | Secondary — IFG is a risk marker but not diabetes; does not meet diagnostic threshold | **Clinical Pearl:** In Indian CVD epidemiology, hypertension is present in ~40–50% of urban adults and accounts for the largest population attributable risk (PAR ~30–40%) for both coronary heart disease and stroke. A patient with untreated stage 2 hypertension for 3 years has already sustained significant vascular remodeling. **High-Yield:** The concept of **absolute cardiovascular risk** integrates all risk factors (age, sex, BP, lipids, smoking, diabetes) into a single 10-year probability estimate. In this patient, hypertension is the dominant risk driver; her other factors (borderline LDL, low HDL, IFG) are **modifiers** but not primary. **Mnemonic:** **HASTE** = **H**ypertension, **A**rterial stiffness, **S**ustained endothelial dysfunction, **T**herapy needed, **E**levated absolute risk.